CompletedACTRN12617000289314
Official study titleA Pilot Trial evaluating the impact of internet-delivered cognitive behavioural therapy (iCBT) program on symptoms of postnatal anxiety and depression: Study 3: The Perinatal MUMentum Program: Postpartum Pilot
This study has finished and is no longer accepting participants.
Multiple locations, including DarlinghurstAnxiety, DepressionInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- St Vincent's Hospital, Sydney
CompletedACTRN12621001006831
Official study titleA pilot trial of a mental health app for Emergency Service Workers: the Build Back Better app; assessing preliminary clinical effectiveness and user preferences
This study has finished and is no longer accepting participants.
In AustraliaAnxiety, DepressionInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- Blackdog Institute
CompletedACTRN12618001475235
Official study titleA pilot trial of a smartphone application to support the mental health of young apprentices
This study has finished and is no longer accepting participants.
In AustraliaAnxiety, DepressionInterventional studyAges 16–30
- Countries
- Australia
- Sponsor
- Mark Deady
CompletedNCT01232790
Official study titleA Pilot Trial of Acute N-Acetylcysteine Effects on Working Memory and Other Cognitive Functions in Schizophrenia
This study has finished and is no longer accepting participants.
In New HavenSchizophreniaPlacebo comparisonAges 18–60
- Countries
- United States
- Sponsor
- Yale University
TerminatedNCT02476708
Official study titleA Pilot Trial of Curcumin Effects on Cognition in Schizophrenia
This study ended early.
In New HavenSchizophreniaPlacebo comparisonAges 18–65
- Countries
- United States
- Sponsor
- Yale University
CompletedNCT00630682
Official study titleA Pilot Trial of Dextroamphetamine for Methamphetamine Dependence
This study has finished and is no longer accepting participants.
In San FranciscoAddictionMedication studyAges 18–50
- Countries
- United States
- Sponsor
- California Pacific Medical Center Research Institute
CompletedACTRN12617000307303
Official study titleA pilot trial on the effectiveness of group metacognitive therapy for perinatal onset obsessive compulsive disorder
This study has finished and is no longer accepting participants.
In AustraliaOCDInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- Curtin University
CompletedNCT01141634
Official study titleA Pilot Trial of Homeopathic Treatment for Attention Deficit Hyperactivity Disorder in Children and Adolescents
This study has finished and is no longer accepting participants.
In TorontoADHDInterventional studyAges 6–16
- Countries
- Canada
- Sponsor
- University of Toronto
CompletedNCT00538655
Official study titleA Pilot Trial of Modafinil for Treatment of Methamphetamine Dependence
This study has finished and is no longer accepting participants.
In San FranciscoAddictionMedication studyAges 18–50
- Countries
- United States
- Sponsor
- California Pacific Medical Center Research Institute
CompletedEUCTR 2020-000437-41
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In ItalySchizophreniaHistorical research record
- Countries
- Italy
- Sponsor
- NEWRON PHARMACEUTICALS SPA
CompletedNCT02476877
Official study titleA Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse
This study has finished and is no longer accepting participants.
In BrooklynSchizophrenia, Bipolarity, ...Observational studyAges 18+
- Countries
- United States
- Sponsor
- Advanced Clinical Laboratory Solutions, Inc.
CompletedNCT02493777
Official study titlePh 3 Multicenter OL Treatment-optimized RDBPC Forced-withdrawal, Parallel Grp Study to Evaluate Safety & Efficacy of Evening Dosed HLD200, a Novel DR/ER Formulation (DELEXIS) of MPH HCl in Children Aged 6-12 With ADHD in Classroom Setting
This study has finished and is no longer accepting participants.
Multiple locations, including Newport BeachADHDMedication studyAges 6–12
- Countries
- United States
- Sponsor
- Ironshore Pharmaceuticals and Development, Inc
